Karyopharm Therapeutics reported $71.65M in Operating Expenses for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Abbott ABT:US $ 8383M 448M
Abbvie ABBV:US $ 9518M 611M
Acceleron Pharma XLRN:US $ 91.6M 3.24M
Amgen AMGN:US $ 5.7B 1.93B
Astrazeneca AZN:US 7.09B 1.67B
AstraZeneca AZN:LN 7.09B 1.67B
Avrobio Inc AVRO:US 31.38M 4.49M
Biocryst Pharmaceuticals BCRX:US $ 79.54M 9.1M
Bristol Myers Squibb BMY:US $ 9.99B 666M
Eli Lilly And LLY:US $ 5336.7M 313.6M
Enanta Pharmaceuticals ENTA:US $ 55.47M 5.64M
Epizyme EPZM:US $ 71.24M 727K
GlaxoSmithKline GSK:LN 6.42B 692M
Johnson & Johnson JNJ:US $ 19.49B 2.84B
Karyopharm Therapeutics KPTI:US $ 71.65M 3.98M
Macrogenics MGNX:US $ 71.04M 2.86M
Merk MRK:US $ 9905M 839M
Mirati Therapeutics MRTX:US $ 164.19M 31.76M
Nektar Therapeutics NKTR:US $ 138.54M 5.5M
Novartis NVS:US 9.82B 464M
Novartis NOVN:VX 9.82B 464M
Pfizer PFE:US $ 13063M 3998M
Regeneron Pharmaceuticals REGN:US $ 1791.3M 375.3M
Sangamo Biosciences SGMO:US $ 76.57M 3.99M
Tg Therapeutics TGTX:US $ 79.04M 10.96M
Ultragenyx Pharmaceutical RARE:US $ 169.75M 36.21M
Xencor XNCR:US $ 58.36M 8.72M
YTE INCY:US $ 564.87M 58.95M